The effect of regular inhaled albuterol on exercise-induced bronchoconstriction

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 1, 1996, Pages 65-69

  Inman, Mark D ^a   O'Byrne, Paul M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO; SALBUTAMOL;

ADULT; ARTICLE; BICYCLE ERGOMETRY; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; EXERCISE; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030042988     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.1.8542164     Document Type: Article

References (30)

1. Anderson, S. D., J. P. Seale, P. Rozea, L. Bandler, G. Theobald, and D. A. Lindsay. 1976. Inhaled and oral salbutamol in exercise-induced asthma. Am. Rev. Respir. Dis. 114:493-500.
2. British Thoracic Society, Research Unit of the Royal College of Physicians of London, Kings Fund Center, National Asthma Campaign. 1990. Guidelines for management of asthma in adults, I: chronic persistent asthma. B.M.J. 301:651-654.
3. Hargreave, F. E., J. Dolovich, and M. T. Newhouse. 1990. The assessment and treatment of asthma: a conference report. J. Allergy Clin. Immunol. 85:1098-1111.
4. Wanner, A. 1995. Is the routine use of inhaled β-adrenergic agonists appropriate in asthma management? Yes. Am. J. Respir. Crit. Care Med. 151:597-599.
5. Sears, M. R., D. R. Taylor, C. G. Print, D. C. Lake, Q. Li, E. M. Flannery, D. M. Yates, M. K. Lucas, and G. P. Herbison. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391-1396.
6. Kerrebijn, K. F., E. E. M. von Essen-Zandvliet, and H. J. Neijens. 1987. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on bronchial responsiveness in asthmatic children. J. Allergy Clin. Immunol. 79:653-659.
7. Vathenen, A. S., A. J. Knox, B. G. Higgins, J. R. Britton, and A. E. Tattersfield, 1988. Rebound increases in bronchial responsiveness after treatment with inhaled terbutaline. Lancet i:554-557.
8. 2-agonist treatment. Am. Rev. Respir. Dis. 148: 707-712.
9. Taylor, D. R., M. R. Sears, G. P. Herbison, C. G. Print, D. C. Lake, D. M. Yates, M. K. Lucas, and Q. Li. 1993. Regular inhaled β-agonist in asthma: effects on exacerbations and lung function. Thorax 48: 134-138.
10. Crane, J., N. Pearce, A. Flatt, C. Burgess, R. Jackson, T. Kwong, M. Ball, and R. Beasley. 1989. Prescribed fenoterol and death from asthma in New Zealand, 1981-1983: case control study. Lancet 1:917-922.
11. Pearce, N., J. Grainger, M. Atkinson, J. Crane, C. Burgess, C. Culling, H. Windom, and R. Beasley. 1990. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-1981. Thorax 45:170-175.
12. Spitzer, W. O., S. Suissa, P. Ernst, R. Horwitz, B. Habbick, D. W. Cockcroft, J. Boivin, M. McNutt, A. S. Buist, and A. S. Rebuck. 1992. The use of β-agonists and risk of death and near death from asthma. N. Engl. J. Med. 326:501-506.
13. Grainger, J., K. Woodman, N. Pearce, J. Crane, C. Burgess, A. Keane, and R. Beasley. 1991. Prescribed fenoterol and death from asthma in New Zealand, 1981-1987: a further case-control study. Thorax 46:105-111.
14. Cockcroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342:833-837.
15. Cockcroft, D. W., P. M. O'Byrne, V. A. Swystun, and R. Bhagat. 1995. Albuterol inhaled regularly and the allergen-induced late asthmatic response. J. Allergy Clin. Immunol. (In press)
16. 2-agonists in asthma. N. Engl. J. Med. 327:1204-1208.
17. Cheung, D., M. C. Timmers, A. H. Zwinderman, E. H. Bel, J. H. Dijkman, and P. J. Sterk. 1992. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 327:1198-1203.
18. Morris, J. F., A. Koski, and L. C. Johnson. 1971. Spirometer standards for healthy non-smoking adults. Am. Rev. Respir. Dis. 103: 57-67.
19. Jones, N. L. 1988. Clinical Exercise Testing, 3rd ed. W. B. Saunders, Philadelphia. 135.
20. Jones, N. L., E. Summers, and K. J. Killian. 1989. Influence of age and stature on exercise capacity during incremental cycle ergometry in men and women. Am. Rev. Respir. Dis. 140:1373-1380.
21. Kraan, J., G. H. Koeter, T. W. Van der Mark, H. J. Sluiter, and K. DeVries. 1985. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 76:628-636.
22. Peel, E. T., and G. J. Gibson. 1980. Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine. Am. Rev. Respir. Dis. 121:973-978.
23. Ramage, L., B. J. Lipworth, C. G. Ingram, I. A. Cree, and D. P. Dhillon. 1994. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir. Med. 88:363-368.
24. Gibson, G. J., J. K. Greenacre, P. Konig, M. E. Conolly, and N. B. Pride. 1978. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br. J. Dis. Chest 72:199-206.
25. Nijkamp, F. P., F. Engels, P. A. J. Henricks, and A. J. M. Van-Oosterhout. 1992. Mechanisms of β-adrenergic receptor regulation in lungs and its implications for physiological responses. Physiol. Rev. 72:323-367.
26. Lipworth, B. J., A. D. Struthers, and D. G. McDevitt. 1989. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am. Rev. Respir. Dis. 140:586-592.
27. Nelson, H. S., D. J. Raine, H. C. Doner, and W. C. Posey. 1977. Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. Am. Rev. Respir. Dis. 116:871-878.
28. Martinsson, A., L. Kjell, and P. Hjemdahl. 1987. Studies in vivo and in vitro of terbutaline-induced β-adrenoceptor desensitization in healthy subjects. Clin. Sci. 72:47-54.
29. Koeter, G. H., H. Meurs, H. F. Kauffman, J. G. R. de Monchy, H. J. Sluiter, and K. de Vries. 1983. Changes in the beta-adrenergic system in bronchial asthma induced by terbutaline. Agents Actions 13(Suppl.): 259-264.
30. Newnham, D. M., D. G. McDevitt, and B. J. Lipworth. 1994. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am. J. Med. 97:29-37.